Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Reinvestment Rate
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting ₩73.91 Billion (capex ₩7.79 Billion plus investments ₩-66.12 Billion) from operating cash flow of ₩61.53 Billion. Check Pharma Reaserch Prod Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharma Reaserch Prod Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Pharma Reaserch Prod Co Ltd across 11 annual periods. Explore Pharma Reaserch Prod Co Ltd (214450) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Pharma Reaserch Prod Co Ltd. For live market cap and broader valuation context, see 214450 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | ₩174.42 Billion | ₩183.16 Billion | ₩35.78 Billion | ▼ -49.6% |
| 2024 | 1.89x | ₩264.26 Billion | ₩139.88 Billion | ₩38.73 Billion | ▲ +112.0% |
| 2023 | 0.89x | ₩57.86 Billion | ₩64.95 Billion | ₩13.20 Billion | ▲ +78.4% |
| 2022 | 0.50x | ₩29.67 Billion | ₩59.40 Billion | ₩17.76 Billion | ▼ -62.6% |
| 2021 | 1.33x | ₩87.07 Billion | ₩65.30 Billion | ₩20.64 Billion | ▲ +12.4% |
| 2020 | 1.19x | ₩38.42 Billion | ₩32.39 Billion | ₩34.78 Billion | ▲ +110.6% |
| 2019 | 0.56x | ₩10.85 Billion | ₩19.27 Billion | ₩9.59 Billion | ▼ -94.5% |
| 2018 | 10.15x | ₩52.80 Billion | ₩5.20 Billion | ₩28.60 Billion | ▲ +603.0% |
| 2017 | 1.44x | ₩12.35 Billion | ₩8.56 Billion | ₩7.63 Billion | ▲ +200.7% |
| 2016 | 0.48x | ₩3.92 Billion | ₩8.16 Billion | ₩1.96 Billion | ▼ -93.5% |
| 2015 | 7.43x | ₩119.09 Billion | ₩16.02 Billion | ₩462.99 Million | — |